NIAID Clinical Research Study Tests HIV Vaccine Regimens
A new NIAID clinical trial is testing the safety of HIV vaccines that use an adenovirus as a transporter. Adenoviruses are naturally occurring viruses that cause cold symptoms or mild eye infections. Transporters may help vaccines stimulate an immune response against HIV. Researchers want to see if different ways of giving the vaccines cause different immune responses. They also want to see if the vaccines’ adenovirus is contagious.
Healthy adults ages 18 to 49 may be eligible to volunteer for this study at the NIH Clinical Center in Bethesda, Maryland. Participants cannot get HIV from these vaccines, but they can get the adenovirus so their entire household and intimate contacts must participate. The total time commitment for this study is one year and all volunteers will be compensated.